Home » FDA Clarifies Adverse Event Reporting Expectations During Influenza Pandemics
FDA Clarifies Adverse Event Reporting Expectations During Influenza Pandemics
Drug manufacturers shouldn’t reduce their adverse event reporting practices during an influenza pandemic, the FDA said.
Drug Industry Daily
Upcoming Events
-
07May
-
14May
-
30May